Your browser doesn't support javascript.
loading
Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.
Lamarca, Angela; Palmer, Daniel H; Wasan, Harpreet Singh; Ross, Paul J; Ma, Yuk Ting; Arora, Arvind; Falk, Stephen; Gillmore, Roopinder; Wadsley, Jonathan; Patel, Kinnari; Anthoney, Alan; Maraveyas, Anthony; Iveson, Tim; Waters, Justin S; Hobbs, Claire; Barber, Safia; Ryder, W David; Ramage, John; Davies, Linda M; Bridgewater, John A; Valle, Juan W.
Afiliação
  • Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX,, UK.
  • Palmer DH; University of Liverpool and Clatterbridge Cancer Centre, Liverpool, UK.
  • Wasan HS; Department of Cancer Medicine, Hammersmith Hospital, Imperial Colllege London, London, UK.
  • Ross PJ; Guy's Cancer, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • Ma YT; Department of Hepatobiliary Oncology, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Arora A; Department of Medical Oncology, University Hospital of Nottingham NHS Trust, University of Nottingham, Nottingham, UK.
  • Falk S; Bristol Haematology and Oncology Centre, Bristol, UK.
  • Gillmore R; Department of Medical Oncology, Royal Free NHS Foundation Trust, London, UK.
  • Wadsley J; Weston Park Cancer Centre, Sheffield, UK.
  • Patel K; Department of Medical Oncology, Cancer and Haematology Centre, Oxford, UK.
  • Anthoney A; Department of Medical Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Maraveyas A; Department of Medical Oncology, Hull University Teaching Hospitals NHS Trust, Hull, UK.
  • Iveson T; Department of Gastro- Intestinal Oncology, University Hospital Southampton NHS Foundation Trust, Southampton University, Southampton, UK.
  • Waters JS; Kent Oncology Centre, Maidstone, UK.
  • Hobbs C; Department of Clinical Oncology, Great Western Hospital, Swindon, UK.
  • Barber S; Manchester Clinical Trials Unit, University of Manchester, Manchester M20 4BX, UK.
  • Ryder WD; Manchester Clinical Trials Unit, University of Manchester, Manchester M20 4BX, UK.
  • Ramage J; Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
  • Davies LM; Manchester Centre for Health Economics, University of Manchester, Manchester M20 4BX, UK.
  • Bridgewater JA; UCL Cancer Institute, University College London, London, UK.
  • Valle JW; Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX,, UK; Division of Cancer Sciences, University of Manchester, Manchester M20 4BX, UK. Electronic address: juan.valle@manchester.ac.uk.
Lancet Oncol ; 22(7): e288-e289, 2021 07.
Article em En | MEDLINE | ID: mdl-34197751
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Neoplasias do Sistema Biliar Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Neoplasias do Sistema Biliar Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article